IPP Bureau
Serum receives green light for Omicron variant vaccine
By IPP Bureau - February 07, 2022
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Mangalam Drugs and Organics Q3FY22 PAT at Rs. 4.02 crore
By IPP Bureau - February 05, 2022
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
Sun Pharma Advanced Research Company Q3FY22 loss at Rs. 15.84 crore
By IPP Bureau - February 05, 2022
Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021
IOL Chemicals and Pharmaceuticals Q3FY22 PAT at Rs. 40.07 crore
By IPP Bureau - February 05, 2022
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
Dishman Carbogen Amcis Q3FY22 PAT at Rs. 35.38 crore
By IPP Bureau - February 05, 2022
Dishman Carbogen Amcis has reported consolidated financial results for the period ended December 31, 2021
Sanofi unveils new corporate brand and logo
By IPP Bureau - February 05, 2022
Sanofi unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December 2019
Expert panel recommends Emergency Use Authorisation for Sputnik Light
By IPP Bureau - February 05, 2022
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Indian govt. places order for five crore doses of Corbevax
By IPP Bureau - February 05, 2022
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Lupin Q3FY22 PAT at Rs 545.52 cr.
By IPP Bureau - February 04, 2022
Lupin has reported consolidated financial results for the period ended December 31, 2021
Pfizer Q3FY22 PAT at Rs 143.91 crore
By IPP Bureau - February 04, 2022
The company has reported standalone financial results for the period ended December 31, 2021.
Sun Pharma demonstrates strong performance on all fronts: ICICI Direct
By IPP Bureau - February 04, 2022
Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses
Thermo Scientific launches Nicolet RaptIR FTIR microscope
By IPP Bureau - February 04, 2022
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
Germfree launches novel mobile cleanroom technology for advanced therapies
By IPP Bureau - February 04, 2022
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
Sir HN Reliance Foundation Hospital partners with Karkinos Healthcare for community cancer screening
By IPP Bureau - February 04, 2022
The target demographic will be those between the ages of 30 and 65 years
AstraZeneca expands ‘Young Health Programme’ to Bengaluru, this World Cancer Day
By IPP Bureau - February 04, 2022
It has signed an MoU with Plan India to expand its reach to Karnataka
